A device designed to help breast surgeons achieve cancer-free margins during lumpectomy surgery appears to be doing well in Germany where it is approved under CE mark. A study expected to be published in an upcoming issue of The Breast journal describes the use of Dune Medical Devices' (Framingham, Massachusetts) MarginProbe system as an adjunct to the standard of care in lumpectomy surgeries of women with early stage ductal carcinoma in situ of the breast.